Sort by
Refine Your Search
-
acute clinical services, and is a part of the CAPS Leadership. KEY RESPONSIBILITIES: This is a 12-month full-time position that assists in the development and implementation of the center's mission and
-
Emergency Management Project Specialist - Office of Critical Event Preparedness and Response (CEPAR)
the development and delivery of presentations that will demonstrate achievement of program goals and objectives, including exercise planning meetings, workshops, tabletop and functional exercise documentation
-
to the Chief of Staff for operational and administrative challenges and follows through to implementation. Oversees the development and maintenance of electronic information systems. Oversees coordination
-
and supports regular communication with project funders and stakeholders. KEY RESPONSIBILITIES: Directs the strategic planning, development and implementation of a large and complex program or
-
postdoctoral fellowship and/or has prior work experience in pediatric chronic pain is strongly preferred. Opportunities for development of groups or other clinical programming is available and supported by
-
productivity. Monitors all physician compensation programs for compliance will all pertinent regulations. Participates in the development and implementation of new systems and databases relating to faculty and
-
limited to, assisting departmental faculty/PI in the development, preparation, and submission of grant and contract proposals. Ensures all applications meet agency and university guidelines and published
-
inquiries requiring interpretation of policies, procedures, and program guidelines. Participates in professional development related to faculty development and higher education (e.g., POD, AAC&U). 2. Academic
-
advanced research. The Manager leads the development of secure, scalable, and innovative computing environments that support analytics, AI/ML, econometrics, behavioral research, and interdisciplinary
-
investigators at these centers to innovate, including the development of belatacept, a novel immunosuppression agent for kidney transplantation. With one of the largest Anatomic/Clinical Pathology (AP/CP